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Abstract
The HIV epidemic in Russia, one of the world’s fastest growing, has been concentrated mostly among people
who inject drugs (PWID). We sought to explore the epidemiology of the epidemic in St. Petersburg by sampling
from the highest risk groups of PWID and men who have sex with men (MSM) and use viral sequencing data to
better understand the nature of the city’s epidemic. Serological testing confirmed an HIV prevalence among
PWID in excess of 40%. All but 1 of 110 PWID whose blood samples were tested for genetic diversity were
infected by subtype A virus, specifically by the AFSU strain. The remaining person was infected with a CRF-
06cpx recombinant. Analysis of pairwise genetic distance among all PWID studied revealed an average of 3.1%
sequence divergence, suggesting clonal introduction of the AFSU strain and/or constraints on sequence diver-
gence. The HIV prevalence was less than 10% among MSM. All 17 sequences from HIV-infected MSM were
found to be a clade B virus with a much higher average sequence diversity of 15.7%. These findings suggest two
independent epidemics with little overlap between the two highest at-risk populations, which will require
different HIV prevention approaches.
Introduction
Beginning in 1996, Russia has witnessed a rapidly ex-panding HIV epidemic. The epidemic began in the
westernmost part of Russia and expanded rapidly.1,2 Newly
diagnosed cases reported to the Russian Federal AIDS Center
(RFAC) increased every year between 1996 and 2001, to-
taling more than 87,000 cases.3,4 Since then, an average of
40,000 new cases have been reported annually, with the
number of new diagnoses exceeding 700,000 at the end of
2012. This makes Russia the only country outside of sub-
Saharan African with the highest population prevalence
of HIV (RFAC data, http://hivrussia.ru/files/bul_38.pdf).
Throughout this period, unsafe injection drug use has been
the predominant mode of HIV transmission.5 Although there
appears to be some expansion of the epidemic beyond people
who inject drugs (PWID), two-thirds of newly diagnosed
infections since 1997 were among people officially identified
as PWID.6
The city of St. Petersburg has been among those most
heavily affected, with around 55,000 cases being diagnosed
(RFAC data, http://hivrussia.ru/files/bul_38.pdf). MSM
HIV transmission in St. Petersburg has been observed since
the beginning of the epidemic in Russia and initially re-
presented intermittent introductions of HIV subtype B from
Western Europe or the United States.1,7,8 Limited data are
available about the HIV prevalence in MSM. One study of
237 MSM recruited from gay clubs in St. Petersburg found a
prevalence of 3.8%,9 and another study of 401 subjects
showed the prevalence of about 6%.10 HIV transmission
among PWID was first noted in 1998 and currently more
than three-quarters of all registered infections in St. Pe-
tersburg (totaling approximately 40,000) are among the
estimated 83,000 PWID.11 The HIV prevalence among
PWID increased linearly from 2% in 1998 to 30% in 2003,
and reached 59% in the most recent studies.12–16 Respondent-
driven sampling (RDS), a chain referral sampling method
commonly used to reach hidden populations, has become the
most popular method to recruit samples of PWID and MSM
in Russia.17,18 These populations have been studied sepa-
rately; however, little is known about crossover between
these groups.15
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The goal of this particular analysis was to explore the
molecular epidemiology of HIV-1 among PWID and MSM
who were recruited simultaneously using a dual high-risk,
peer-driven chain referring sampling scheme.19 By allowing
PWID to recruit MSM and vice versa, we maximized the




The Sexual Acquisition and Transmission of HIV-
Cooperative Agreement Program (SATH-CAP) was an NIDA-
funded, cross-sectional study of high-risk groups (PWID,
MSM, and sex partners of both groups) recruited in 2006–
2008 by a modified form of RDS.19 Individuals who belong
to the core populations of drug users and MSM and met the
inclusion criteria for the study were recruited as seeds and
recruitment continued to create chains of individuals in the
core risk group populations that expand beyond the seed’s
own drug using or MSM network. In addition, the members
of the core risk groups were instructed and encouraged to
recruit their sexual partners who were not members of the
core risk groups into the study.
All study procedures were approved by institutional re-
view boards at The Biomedical Center, Yale University, and
RAND Corporation.
Recruited participants completed structured interviews
and answered detailed questions about their drug use and
sexual behaviors, their HIV testing history, and their social
and drug using networks. The participants were classified
into several major categories: (1) people who inject drugs
(PWID), (2) people who use noninjectable drugs (PWUD),
(3) men who have sex with men (MSM), (4) combined
groups (MSM/PWUD and MSM/PWID), and (5) sex part-
ners (non PWID/PWUD/MSM).
After pretest counseling, blood samples were taken to
ascertain their HIV status by an enzyme-linked immuno-
assay (EIA) that was confirmed by Western blot. Among
those individuals who were found to be HIV positive, the
incidence of recent infection cases was estimated using a
BED Capture Enzyme Immunoassay (Calypte Inc.). How-
ever, since the BED assay is known for overestimation of
the incidence cases, we adjusted the BED results using
participants’ self-reported data. Those individuals who were
aware of their HIV-positive status for 6 months and longer
were removed from the group of BED-determined recent
infection cases.
The participants who knew their HIV-positive status for 1
year or longer were assigned to the subgroup of chronically
infected cases.
Genotyping and phylogenetic analysis
Aliquots of blood were stored at - 80C until viral RNA
was extracted from serum samples using a Viral RNA Ex-
traction kit (Qiagen). Reverse transcriptase polymerase chain
reactions (RT-PCR) were carried out to amplify the env V3
region. For this purpose, we used either a one-step or two-step
protocol, with a One-Step RT-PCR kit (Qiagen) or Super-
Script III and Platinum Taq polymerases (Invitrogen), re-
spectively. Viral RNA was extracted from 240 ll of sera. For
the one-step reaction, we took 25 ll of extracted RNA. For
cDNA synthesis in the two-step protocol, we used 15 ll of
RNA. As a template for the first round of PCR, we took 1 ll of
cDNA. The second round of PCR was carried out only for
the env region; 1 ll of the first round mix was used as a
template. The following primer sequences were used: for the
first round of PCR—ES7-1 (5¢-AATGTCAGCACAGTAC
ARTGYACNCA-3¢, HXB2 6945–6970) and ES8-1 (5¢-CC
ATAGTRCTTCCTGCTGYTCCYAAGA-3¢, HXB2 7789–
7815); for the second round of PCR and sequencing—ES7
(5¢-CTGTTAAATGGCAGTCTAGC-3¢, HXB2 7002–7021)
and ES8 (5¢-CACTTCTCCAATTGTCCCTCA-3¢, HXB2
7648–7668).
PCR fragments were subjected to direct sequencing using
MegaBACE1000 sequencer (Amersham Biosciences) using
the DYEnamic ET Dye Terminator Cycle Sequencing Kit
(Amersham Biosciences) according to the manufacturer’s
protocol. The sequence data were analyzed using Sequencher
4.7 and nucleotide sequences were edited and assembled
using the BioEdit 7.0.5.2 software (www.mbio.ncsu.edu/
BioEdit/bioedit.html). Our sequences were aligned with the
subtype-specific reference sequences obtained from the Los
Alamos HIV Database (www.hiv.lanl.gov).
Phylogenetic analysis was conducted using MEGA 5.2.20
Neighbor-joining trees were tested by the bootstrap method
(500 bootstrap replications) using the Kimura two-parameter
model. A viral cluster with a bootstrap value of 60 or more
was considered as a potential transmission cluster.








Men who have sex with men (MSM) 224 18 (8.0%) M (100%) 26 (18–58)
People who use noninjectable drugs (PWUD) 18 3 (16.7%) F (45%)
M (55%)
24 (18–42)
People who inject drugs (PWID) 684 309 (45.2%) F (26.9%)
M (73.1%)
29 (18–53)
MSM/PWUD 7 0 (0.0%) M (100%) 22 (19–26)
MSM/PWID 7 3 (42.9%) M (100%) 28 (23–36)
Sex partners, non-MSM/PWUD/PWID 83 9 (10.8%) F (63.9%)
M (36.1%)
28 (18–58)
Total 1023 342 (33.4%) F (24%)
M (76%)
28 (18–58)
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The nucleotide and amino acid diversity was calculated
using the p-distance model in MEGA. The differences be-
tween the groups were assessed using the Mann–Whitney test
and plotted in Prism 6.0 (GraphPad Software, La Jolla, CA).
All HIV-1 env nucleotide sequences were submitted to
the GenBank database under accession numbers FJ233960,
FJ233974-FJ233991, FJ233993, FJ233997, FJ233999-
FJ234004, FJ234006, FJ234008-FJ234009, FJ234011-
FJ234016, FJ234018-FJ234020, FJ234022-FJ234024,
FJ234026-FJ234028, FJ234031-FJ234062, KP319348-
KP319379 for subtype A and KP100401-KP100417 for
subtype B.
Results
The recruitment of the study subjects was conducted in
2006–2008. The HIV prevalence in the PWID group was
45.2% and in the MSM group was 8%. Although allowing for
FIG. 1. Phylogenetic analysis of the plasma-derived env fragments of HIV-1 subtype A. Closed triangles mark the sequences
obtained from blood samples of people who inject drugs (PWID) who were HIV positive for less than 6 months (recent infection
cases); closed circles show the sequences obtained from blood samples of PWID who were HIV positive for 12 month or more
(chronic infection cases); open squares represent the strains obtained from PWID with an unknown duration of infection. For
convenience, all titles of SATH-CAP sequences start with the two digits of the sampling year (2006, 07, or 08); titles of recent and
chronic infection cases end with r or c, respectively. Unlabeled branches show the subtype A reference strains.
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cross referrals between the MSM and PWID groups, we found
them to be an infrequent event. Only 1.6% of PWID were
recruited by MSM and 4.0% of MSM were recruited by PWID.
Furthermore, only 22 individuals (2.4%) were jointly PWID
and MSM and 10 of them (45.5%) were HIV positive (Table 1).
We genotyped viral strains from 127 individuals (110
from PWID and 17 from MSM) using a portion of the env
gene in the V3 region. The final sets of sequences included
the fragments with HXB2 coordinates of 7068–7564 bp for
subtype A and 7137–7598 bp for subtype B. The number of
analyzed MSM samples was significantly lower due to
dramatic differences in prevalence (Table 1). Eight MSM
blood samples came from the study participants recruited
through RDS, and nine were obtained from the unrelated
MSM patients of the City AIDS Center who did not report
the use of injectable drugs. Two samples came from RDS-
recruited men who reported both drug use (one person re-
ported injectable and one reported single use of non-
injectable drugs) and sex with other men. Broadly speaking,
the sequence data revealed two distinct and nonoverlapping
epidemics of HIV subtypes A and B.
Among samples obtained from PWID, all but one indi-
vidual harbored HIV of subtype A1 commonly observed in
former Soviet Union (FSU) countries (Fig. 1). The one non-
A1 sequence belonged to the family of complex recombinant
CRF06_cpx and its subsequent recombinant with A1, CRF06-
cpx/A1, and was analyzed for full-length env gene elsewhere.21
Bootstrapping analysis of the env sequences revealed nine pairs
of sequences from PWID that were very closely related. Using
the coupon system of RDS, we discerned that four of these pairs
represented individuals who reported either sharing drugs or
having sex with each other. In addition, three pairs were part of
the same recruitment network.
From among the 110 PWID whose HIV was amenable to
sequencing, we used two methods—self-reported data on
HIV test history and the BED assay that detects individuals
recently infected with HIV22 with high probability—to
identify 27 individuals who by both assays were recently
infected. All but one of the env sequences belonged to the
AFSU subtype; the other one was the CRF06-cpx/A1 strain.
The median pairwise genetic diversity for all subtype A
sequences studied was 3%; the average was 3.1% (range
0–12.9%). Within the subgroup of 26 individuals recently
infected with subtype AFSU the nucleotide sequence diversity
ranged from 1% to 9.6% with the median value of 5.1%. In
contrast, 16 individuals who reported being infected with
AFSU at least 365 days before providing the sample we ana-
lyzed (subgroup of chronic infection) had pairwise genetic
diversity that ranged from 3.5% to 9.5% with the higher
median value of 6.6% (Fig. 2A). The median amino acid
diversity for the recent infection subgroup was 12.1% (range
3.4–24.8%) and for the chronic infection subgroup was
14.8% (range 8.1–20%) (Fig. 2B). All the differences be-
tween the subgroups were statistically significant.
The epidemiological profile of the HIV-1 epidemic among
MSM in St. Petersburg differs from the injection-related
epidemic. All 17 blood samples obtained from MSM har-
bored HIV-1 strains of subtype B (Fig. 3). The pairwise ge-
netic diversity of subtype B sequences ranged from 5.4% to
20.9% with a median value of 16% (Fig. 2). The median
amino acid diversity for the MSM group was 25.1% (range
11–35.2%) (Fig. 2B).
Of the two men who reported both having sex with other
men and a history of drug use, one of them harbored the
strains of subtype AFSU commonly observed in PWID while
the other had HIV strains of subtype B.
No sequence comparisons for sexual partners or for indi-
viduals within the same recruitment chain were possible due
to the low number of HIV-positive subjects among the re-
cruited individuals.
FIG. 2. Nucleotide and amino acid diversity of HIV-1 subtype A and B env fragments. (A) Genetic diversity of recently
transmitted subtype A strains is lower than that of persistent subtype A and B strains. Patterned bars represent the p-
distance values obtained for the nucleotide sequences derived from two subgroups of subtype A: infected PWID and recent
and chronic infection cases; open bar represents the values obtained for the nucleotide sequences of subtype B-infected men
who have sex with men (MSM). (B) Amino acid diversity of recently transmitted subtype A strains is lower than that of
persistent subtype A and B strains. Patterned bars represent the p-distance values obtained for the amino acid sequences
derived from two subgroups of subtype A-infected PWID (recent and chronic infection cases); open bar represents the
values obtained for the nucleotide sequences of subtype B-infected MSM.
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Discussion
Our data suggested that PWID and MSM constitute largely,
but not completely, separate populations. The low frequency
of cross-referrals and the low number of men who reported
both injection drug use and sex with other men have kept the
two epidemics of HIV-1 largely separate. The limited genetic
data from the two MSM who used drugs do suggest that if the
overlap were greater, more mixing would have occurred.
The genetic diversity of the AFSU sequences remained
relatively low even among individuals who had been, ac-
cording to their reported testing histories, HIV positive for
many years. HIV generally evolves rapidly once infection has
been established,23 but that does not seem to be the case for
the AFSU strain. In this study low genetic diversity was de-
tected in cases of recent and chronic infection using the se-
quencing method that reveals only the predominant sequence
within an infected individual. The genetic bottleneck was
also observed studying the individual strains of transmitted
virus in acutely infected PWID, when the analysis focused on
the single copies of the full-length env gene.21
While we do not have sufficient information on the bio-
logical properties of the viruses to explain the low diver-
sity, the behavioral patterns may shed some light on this
phenomenon. Notably, the analysis of the history of drug
use of our participants did not reveal any correlations
between PWID experience (years of drug use) and recent
HIV infection acquisition. Analyzing these data together
with the genetic bottleneck phenomenon we may specu-
late that the PWID risk network structure may contribute to
the likelihood of infection. Acute HIV-1 infection is asso-
ciated with a high viral load and thus an increased likeli-
hood of transmission. It is known that within the network
PWID in St. Petersburg do share syringes and injection
paraphernalia frequently,15,24,25 allowing the infection of
the PWID network members to occur very rapidly after
FIG. 3. Phylogenetic analysis of the plasma-derived env fragments of HIV-1 subtype B. Closed triangles indicate the sequences
obtained from the blood samples of MSM within our study; other branches represent the subtype B reference strains and subtype
A outgroup. For convenience, all titles of SATH-CAP sequences start with the two digits of the sampling year (2006, 07, or 08).
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HIV-1 acquisition and viral load spike of a single mem-
ber of this network. The homogeneous acute infection as a
source of the epidemic may explain the low diversity of
the virus circulating in the population.
Conclusions
The sequence data of the env genomic region demonstrate
that two parallel epidemics of HIV exist within the city of St.
Petersburg. The subtype found among MSM was subtype B
unless they also reported injected drug use, in which case
some species were subtype A, suggestive of transmission
through unsafe injection, and others were subtype B, sug-
gestive of transmission through unsafe sex. Given the high
prevalence among PWID and the limited resources for pre-
vention, prevention programs must first concentrate on the
PWID epidemic. Indeed, epidemic modeling of the SATH-
CAP data published elsewhere concludes that if transmission
among PWID were stopped, there would be no further ex-
pansion into the heterosexual population of St. Petersburg.16
HIV-1 transmission within the acute infection window,
which is characterized by high viremia and a high probability
of transmission, should be studied in the context of PWID
risk networks, and the specific surveillance systems for de-
tection of acute HIV-1 infection that exists in many countries
should be implemented in the health system of St. Petersburg.
Programs for both primary prevention—to keep uninfected
individuals from becoming infected—and secondary pre-
vention—to reduce the transmission from those already in-
fected, including people with acute HIV infection—need to
be expanded to contain this growing epidemic.
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